Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors.
Bacterial pneumonia is a common and dangerous illness. Mononuclear phagocytes, which comprise monocyte, resident and recruited macrophage, and dendritic cell subsets, are critical to antimicrobial defenses, but the dynamics of their recruitment to the lungs in pneumonia is not established. We hypothesized that chemokine-mediated traffic of mononuclear phagocytes is important in defense against bacterial pneumonia. In a mouse model of Klebsiella pneumonia, circulating Ly6C(hi) and, to a lesser extent, Ly6C(lo) monocytes expanded in parallel with accumulation of inflammatory macrophages and CD11b(hi) dendritic cells and plasmacytoid dendritic cells in the lungs, whereas numbers of alveolar macrophages remained constant. CCR2 was expressed by Ly6C(hi) monocytes, recruited macrophages, and airway dendritic cells; CCR6 was prominently expressed by airway dendritic cells; and CX3CR1 was ubiquitously expressed by blood monocytes and lung CD11b(hi) dendritic cells during infection. CCR2-deficient, but not CCL2-, CX3CR1-, or CCR6-deficient animals exhibited worse outcomes of infection. The absence of CCR2 had no detectable effect on neutrophils but resulted in reduction of all subsets of lung mononuclear phagocytes in the lungs, including alveolar macrophages and airway and plasmacytoid dendritic cells. In addition, absence of CCR2 skewed the phenotype of lung mononuclear phagocytes, abrogating the appearance of M1 macrophages and TNF-producing dendritic cells in the lungs. Taken together, these data define the dynamics of mononuclear phagocytes during pneumonia.
P.O. Box 800546, Charlottesville, VA 22908. mehrad@virginia.edu.
Lanlin
L
Chen
Zhimin
Z
Zhang
Kathryn E
KE
Barletta
Marie D
MD
Burdick
Borna
B
Mehrad
D000818:Animals; D000073883:CX3C Chemokine Receptor 1; D018932:Chemokine CCL2 / Q000502:physiology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005434:Flow Cytometry; D006090:Gram-Negative Bacteria / Q000276:immunology / Q000472:pathogenicity; D016676:Macrophages, Alveolar / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D009000:Monocytes / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D009195:Peroxidase / Q000378:metabolism; D010586:Phagocytes / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D011014:Pneumonia / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D054390:Receptors, CCR2 / Q000502:physiology*; D054399:Receptors, CCR6 / Q000502:physiology*; D019707:Receptors, Chemokine / Q000502:physiology*
C498126:CCR6 protein, mouse; D000073883:CX3C Chemokine Receptor 1; C491768:Ccl2 protein, mouse; C515335:Ccr2 protein, mouse; D018932:Chemokine CCL2; C471885:Cx3cr1 protein, mouse; D054390:Receptors, CCR2; D054399:Receptors, CCR6; D019707:Receptors, Chemokine; D009195:Peroxidase
chemokine; host defense; pneumonia